vedolizumab
vedolizumab is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Entyvio, ENTYVIO, ENTYVIO Pen. Available dosage forms: injection, powder, lyophilized, for solution, injection, solution.
Drug Details
- Generic Name
- vedolizumab
- Brand Names
- Entyvio, ENTYVIO, ENTYVIO Pen
- Application Number
- BLA125476
- Sponsor
- Takeda Pharmaceuticals America, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, INJECTION, SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- VEDOLIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE ENTYVIO is indicated in adults for the treatment of: moderately to severely active ulcerative colitis (UC). moderately to severely active Crohn's disease (CD). ENTYVIO is an integrin receptor antagonist indicated in adults for the treatment of: moderately to severely active ulcerative colitis (UC). ( 1 ) moderately to severely active Crohn's disease (CD). ( 1 )